Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]        
Product sales, net $ 3,028 $ 3,256 $ 9,208 $ 10,482
Revenue, product and service [Extensible List] us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember us-gaap:ProductMember
Cost of goods sold $ 1,514 $ 1,677 $ 4,682 $ 5,401
Gross profit 1,514 1,579 4,526 5,081
Operating expenses:        
Research and development 19 24 55 104
Selling, general and administrative 1,618 1,830 5,213 5,894
Gain on legal settlement (Note 9) (500) 0 (500) 0
Benefit from reversal of accrued payroll taxes (Note 12) 0 0 0 (522)
Total operating expenses 1,137 1,854 4,768 5,476
Operating income (loss) 377 (275) (242) (395)
Other expense (income):        
Gain on extinguishment of debt 0 0 (20) (38)
Loss on debt conversions 263 0 512 0
Change in fair value of convertible notes 207 0 678 0
Interest expense, net 0 107 94 388
Total other expense 470 107 1,264 350
Loss before income taxes (93) (382) (1,506) (745)
Income tax expense 0 0 5 7
Net loss $ (93) $ (382) $ (1,511) $ (752)
Weighted average common shares outstanding, basic (in shares) 226,096 184,264 207,803 184,264
Weighted average common shares outstanding, diluted (in shares) 226,096 184,264 207,803 184,264
Net loss per common share, basic (in USD per share) $ (0) $ (0) $ (0.01) $ (0)
Net loss per common share, diluted (in USD per share) $ (0) $ (0) $ (0.01) $ (0)